Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Zevra Therapeutics, Inc. (ZVRA) had Cash Flow from Investing Activities of $111.07M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$39.66M |
|
$8.39M |
|
$1.52M |
|
$38.14M |
|
$22.89M |
|
$16.78M |
|
$-3.98M |
|
$12.79M |
|
$12.79M |
|
$8.75M |
|
$8.75M |
|
$8.75M |
|
$8.75M |
|
$16.78M |
|
$16.55M |
|
59.16M |
|
61.34M |
|
$0.14 |
|
$0.14 |
|
| Balance Sheet Financials | |
$251.30M |
|
$0.64M |
|
$51.41M |
|
$302.71M |
|
$48.63M |
|
-- |
|
$36.43M |
|
$85.06M |
|
$217.65M |
|
$207.16M |
|
$217.65M |
|
59.34M |
|
| Cash Flow Statement Financials | |
$23.17M |
|
|
Cash Flow from Investing Activities |
$111.07M |
$-51.22M |
|
$62.41M |
|
$145.32M |
|
$82.92M |
|
$6.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
96.16% |
|
42.30% |
|
42.30% |
|
-- |
|
32.26% |
|
21.16% |
|
$22.92M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.62 |
|
1.76 |
|
51.03 |
|
4.02% |
|
4.22% |
|
2.89% |
|
4.02% |
|
$3.67 |
|
$0.37 |
|
$0.38 |
|